摘要
Introduction
More than 30% of intracerebral hemorrhage (ICH) patients have persistent cognitive impairment after apparent clinical remission, a condition termed delayed-onset injury (DOI). Neuroinflammation in regions remote from the hematoma has been implicated, but how the injury signal reaches those regions, and how it produces memory decline, remain unresolved. We asked whether extracellular vesicles released from the damaged, barrier-disrupted microvasculature carry that signal.
Methods
ICH was induced in mice by stereotaxic collagenase injection into the thalamus. Hippocampal neuroinflammation was assessed 7 and 14 days later by CD11b and IBA-1 immunostaining, and memory was tested with the Barnes maze and the passive avoidance test. Exosome secretion was blocked with GW4869. Brain microvessel exosomes were isolated by ultracentrifugation (UC) or ultrafiltration (UF) and characterized by nanoparticle tracking analysis. ICH-derived microvessel exosomes were then injected into the ventricles of wild-type mice.
Results
ICH mice showed more CD11b- and IBA-1-positive cells in the hippocampus than vehicle-injected mice, indicating microglial activation remote from the hematoma. At day 7, ICH mice also performed significantly worse than vehicle controls on the Barnes maze and the passive avoidance test. Blocking exosome secretion with GW4869 attenuated both the microglial activation and the memory deficit. UC yielded exosomes of higher purity from brain microvessels than UF. Injecting ICH-derived microvessel exosomes into the ventricles of wild-type mice increased the number of CD11b-positive cells.
Conclusions
Exosomes released from damaged, barrier-disrupted microvessels propagate neuroinflammation to remote brain regions and contribute to delayed-onset cognitive impairment after ICH. Targeting extracellular vesicle release may offer a therapeutic strategy for post-ICH cognitive decline
